Count Down to relaunch

Arab Drug eyes EGP 116M in FY 2021/2022

Arab Drug eyes EGP 116M in FY 2021/2022

ArabFinance: The Arab Drug Company (ADCI) has targeted a net profit of EGP 116.3 million for the fiscal year (FY) 2021/2022, the company said in a statement to the Egyptian Exchange on April 31st.

The ordinary general assembly approved the estimated budget for FY 2021/2022.

It is worth mentioning that the company allocated an investment plan of EGP 129.7 million for FY 2021/2022.

The company reported an 18% Year on Year increase in its net profit during the July-February period of FY 2020/2021, recording EGP 94.289 million.

 Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.

#Related keywords


Recommended Stocks

04 Oct 2021
United Housing & Development UNIT

All rights reserved to Arab Finance 2020 ©

Back to top